Dr. Joseph Friedman, MD

NPI: 1477549632
Total Payments
$18,203
2024 Payments
$171.50
Companies
7
Transactions
30
Medicare Patients
2,235
Medicare Billing
$253,140

Payment Breakdown by Category

Research$13,326 (73.2%)
Consulting$3,725 (20.5%)
Food & Beverage$581.50 (3.2%)
Education$570.00 (3.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $13,326 1 73.2%
Consulting Fee $3,725 1 20.5%
Food and Beverage $581.50 22 3.2%
Education $570.00 6 3.1%

Payments by Type

Research
$13,326
1 transactions
General
$4,877
29 transactions

Top Paying Companies

Company Total Records Latest Year
ACADIA Pharmaceuticals Inc $13,971 8 $0 (2019)
Acorda Therapeutics, Inc $3,725 1 $0 (2020)
Amneal Pharmaceuticals LLC $217.36 14 $0 (2024)
INSIGHTEC,INC $134.36 1 $0 (2022)
Neurocrine Biosciences, Inc. $73.16 1 $0 (2023)
Allergan Inc. $70.56 4 $0 (2017)
Mitsubishi Tanabe Pharma America, Inc. $11.39 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $171.50 12 Amneal Pharmaceuticals LLC ($171.50)
2023 $119.02 3 Neurocrine Biosciences, Inc. ($73.16)
2022 $134.36 1 INSIGHTEC,INC ($134.36)
2020 $3,725 1 Acorda Therapeutics, Inc ($3,725)
2019 $540.00 5 ACADIA Pharmaceuticals Inc ($540.00)
2018 $41.39 2 ACADIA Pharmaceuticals Inc ($30.00)
2017 $13,471 6 ACADIA Pharmaceuticals Inc ($13,401)

All Payment Transactions

30 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/19/2024 Amneal Pharmaceuticals LLC ONGENTYS (Drug) Food and Beverage In-kind items and services $9.29 General
Category: NEUROLOGY
10/21/2024 Amneal Pharmaceuticals LLC CREXONT (Drug) Food and Beverage In-kind items and services $14.85 General
Category: NEUROLOGY
08/20/2024 Amneal Pharmaceuticals LLC ONGENTYS 50MG CAPSULES 30 (Drug) Food and Beverage In-kind items and services $12.08 General
Category: NEUROLOGY
08/05/2024 Amneal Pharmaceuticals LLC ONGENTYS 50MG CAPSULES 30 (Drug) Food and Beverage In-kind items and services $13.74 General
Category: NEUROLOGY
05/23/2024 Amneal Pharmaceuticals LLC ONGENTYS (Drug) Food and Beverage In-kind items and services $14.55 General
Category: NEUROLOGY
05/21/2024 Amneal Pharmaceuticals LLC RYTARY (Drug) Food and Beverage In-kind items and services $14.56 General
Category: NEUROLOGY
04/09/2024 Amneal Pharmaceuticals LLC RYTARY (Drug) Food and Beverage In-kind items and services $14.78 General
Category: NEUROLOGY
03/19/2024 Amneal Pharmaceuticals LLC RYTARY (Drug) Food and Beverage In-kind items and services $12.57 General
Category: NEUROLOGY
02/26/2024 Amneal Pharmaceuticals LLC RYTARY (Drug) Food and Beverage In-kind items and services $11.68 General
Category: NEUROLOGY
02/07/2024 Amneal Pharmaceuticals LLC RYTARY (Drug) Food and Beverage In-kind items and services $25.66 General
Category: NEUROLOGY
01/23/2024 Amneal Pharmaceuticals LLC RYTARY (Drug) Food and Beverage In-kind items and services $14.96 General
Category: NEUROLOGY
01/03/2024 Amneal Pharmaceuticals LLC RYTARY (Drug) Food and Beverage In-kind items and services $12.78 General
Category: NEUROLOGY
12/04/2023 Amneal Pharmaceuticals LLC RYTARY (Drug) Food and Beverage In-kind items and services $29.46 General
Category: NEUROLOGY
08/21/2023 Amneal Pharmaceuticals LLC RYTARY (Drug) Food and Beverage In-kind items and services $16.40 General
Category: NEUROLOGY
05/15/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $73.16 General
Category: Neuropsychiatry
03/23/2022 INSIGHTEC,INC Exablate (Device) Food and Beverage Cash or cash equivalent $134.36 General
Category: Neurology
06/11/2020 Acorda Therapeutics, Inc INBRIJA (Drug) Consulting Fee Cash or cash equivalent $3,725.00 General
Category: PARKINSONS DISEASE
07/15/2019 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Education In-kind items and services $250.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
07/15/2019 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Education In-kind items and services $250.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
07/09/2019 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Education In-kind items and services $30.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
02/01/2019 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Education In-kind items and services $5.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
02/01/2019 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Education In-kind items and services $5.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
10/30/2018 ACADIA Pharmaceuticals Inc NUPLAZID (Drug) Education In-kind items and services $30.00 General
Category: PARKINSONS DISEASE PSYCHOSIS
05/02/2018 Mitsubishi Tanabe Pharma America, Inc. Radicava (Drug) Food and Beverage Cash or cash equivalent $11.39 General
Category: Amyotrophic Lateral Sclerosis
08/04/2017 Allergan Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.88 General
Category: NEUROSCIENCE

Research Studies & Clinical Trials

Study Name Company Amount Records
ACP-103-015 ACADIA Pharmaceuticals Inc $13,326 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 447 733 $245,503 $59,044
2022 4 481 762 $242,814 $58,232
2021 4 567 954 $252,459 $73,809
2020 7 740 994 $234,896 $62,055
Total Patients
2,235
Total Services
3,443
Medicare Billing
$253,140
Procedure Codes
18

All Medicare Procedures & Services

18 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 317 583 $175,483 $41,207 23.5%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 66 66 $34,320 $9,071 26.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 64 84 $35,700 $8,767 24.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 341 606 $179,502 $42,297 23.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 78 94 $38,990 $10,187 26.1%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 38 38 $19,376 $4,658 24.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 24 24 $4,946 $1,089 22.0%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 409 789 $202,773 $58,538 28.9%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 68 68 $26,452 $7,149 27.0%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 41 48 $16,560 $5,645 34.1%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 49 49 $6,674 $2,477 37.1%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 408 633 $162,681 $36,701 22.6%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2020 164 189 $18,458 $11,364 61.6%
99204 New patient office or other outpatient visit, typically 45 minutes Facility 2020 83 83 $32,287 $8,439 26.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 25 28 $9,660 $2,517 26.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 31 31 $4,754 $1,228 25.8%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 12 12 $5,868 $1,171 20.0%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Facility 2020 17 18 $1,188 $635.02 53.5%

About Dr. Joseph Friedman, MD

Dr. Joseph Friedman, MD is a Neurology healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477549632.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Friedman, MD has received a total of $18,203 in payments from pharmaceutical and medical device companies, with $171.50 received in 2024. These payments were reported across 30 transactions from 7 companies. The most common payment nature is "" ($13,326).

As a Medicare-enrolled provider, Friedman has provided services to 2,235 Medicare beneficiaries, totaling 3,443 services with total Medicare billing of $253,140. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Providence, RI
  • Active Since 09/23/2005
  • Last Updated 07/25/2024
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1477549632

Products in Payments

  • NUPLAZID (Drug) $13,971
  • INBRIJA (Drug) $3,725
  • RYTARY (Drug) $152.85
  • Exablate (Device) $134.36
  • INGREZZA (Drug) $73.16
  • VRAYLAR (Drug) $70.56
  • ONGENTYS 50MG CAPSULES 30 (Drug) $25.82
  • ONGENTYS (Drug) $23.84
  • CREXONT (Drug) $14.85
  • Radicava (Drug) $11.39

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Providence